Мутационный профиль подтипов острого миелоидного лейкоза у детей при отсутствии известных хромосомных перестроек
Л. Г. Гукасян, Г. С. Краснов, Olga V. Muravenko et al. · Molecular Biology · 2019
The discovery of novel significant molecular and genetic markers is important for the diagnostics, prognosis, and therapy selection in hematological malignancies. Distinct cytogenetic aberrations leading to the formation of fusion genes are found in more than 40% of pediactric cases of acute myeloid leukemia (AML); however, the tumor cells in approximately 20% of these patients display cytogenetically normal karyotype (NK-AML). Here we present the analysis of the mutational profiles of leukemic cells collected from pediatric AML cases without known clinically significant chromosomal aberrations aimed at identifying AML specific markers. In 34 pediatric cases of different AML types, the coding regions of 26 genes involved in the AML pathogenesis were analyzed by massive parallel sequencing. Sequencing revealed the somatic mutations in genes that are involved in various intracellular signaling pathways, including the CEBPA, ETV, IDH1, JAK2, and NRAS genes. In addition, rare genetic variants were found in CUX1, FLT3, TET2, PTPN11, and NUP98 genes. This data may contribute to the understanding of the mechanisms of malignant cell transformation in the case of leukemogenesis.
Cited by 0 works. doi:10.1134/s002689841903008x
Authors
References
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- IDH1andIDH2Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia WithNPM1Mutation WithoutFLT3Internal Tandem Duplication
- Cooperating gene mutations in acute myeloid leukemia: a review of the literature
- C/EBPα mutations in acute myeloid leukaemias
- Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity
- Implications of NRAS mutations in AML: a study of 2502 patients